Specialist diabetes services will conduct a thorough assessment, including: Review of your diabetes history and current medications Assessment of cardiovascular risk factors Evaluation of potential contraindications and precautions Discussion of treatment goals, including weight management Education on injection technique (for injectable formulations) Monitoring plan for efficacy and tolerability NICE recommends that GLP-1 therapy should be reviewed at six months
The study showed that after a mean follow-up period of 3 years, the addition of sitagliptin to the conventional pharmacological treatment did not have a significant effect on rates of major adverse cardiovascular events or hospitalization for heart failure
Still, if youre suffering and displaying other symptoms, its best to play things safe and seek out medical treatment
Furthermore, the cardiovascular benefits emerged early in treatment, preceding significant weight loss, suggesting that the cardiovascular effects may be mediated, at least partially, by other salutary processes in atherosclerotic protection
Read them in full before completing your Medvi intake form or submitting payment
Mortensen, K., Christensen, L
